A matrix approach to guide IHC‐based tissue biomarker development in oncology drug discovery

E-ISSN： 1555-2039|232|2|190-198

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.232, Iss.2, 2014-01, pp. : 190-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of biomarker usage on oncology drug development

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 38, Iss. 1, 2013-02 ,pp. : 62-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of biomarker usage on oncology drug development

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 269-4727, Iss. 1, 2013-02 ,pp. : 62-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mass spectrometry-based tissue proteomics for cancer biomarker discovery

By Balgley Brian M Wang Weijie De Voe Don L Lee Cheng S

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 45-58

Future Medicine

Access to resources Recommend Favorite

Model‐Based Drug Development in Oncology: What's Next?

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 4, 2013-04 ,pp. : 303-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

Network‐Based Approaches in Drug Discovery and Early Development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 6, 2013-12 ,pp. : 651-658

John Wiley & Sons Inc

Access to resources Recommend Favorite